PANCYTOPENIA FROM "MESANTOIN"
- 18 December 1948
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 138 (16), 1148-1150
- https://doi.org/10.1001/jama.1948.02900160016006
Abstract
"Mesantoin" (3-methyl-5,5-phenylethyl hydantoin) is one of the newer anticonvulsant drugs and is chemically and pharmacologically related to "dilantin" (diphenylhydantoin sodium). Kozol1and Loscalzo2reported that this drug is effective in the control of grand mal seizures and may be useful in patients who are refractory or intolerant to "dilantin." They noted no serious toxicities, although "in about 40 per cent of the cases the lymphocytes were moderately increased at the expense of the neutrophiles."2Cutaneous eruptions have occurred in 4.5 to 14 per cent of the cases,3and Ruskin4recently reported a fatal case of dermatitis bullosa medicamentosa due to "mesantoin." A search of the literature reveals only mention of 1 case of serious blood dyscrasia ascribed to "mesantoin" alone.5On review of the case of fatal aplastic anemia following the use of "tridione" (trimethadione) reported by Harrison and his co-workers;6it isThis publication has 1 reference indexed in Scilit:
- TWO NEW DRUGS IN EPILEPSY THERAPYAmerican Journal of Psychiatry, 1946